baber/WOPTO huggingface dataset:
Patent ES-488191-A0 (ES)
IPC: C07C/
Filed: 1980-02-01
Abstract: For all designated states : BE, CH, DE, FR, GB, IT, LU, NL, SE 1. S-(+)-alpha-[methylamino)methyl]-9-10-ethano anthracene-9(10H)-ethanol of the formula I  see diagramm : EP0014434,P11,F1  or an acid addition salt thereof. For the contracting state : AT 1. A process for the production of S-(+)-alpha-([methylamino)methyl]-9-10-ethano anthracene-9(10H)-ethanol of the formula I ad indicated in claim 1, or of an acid addition salt thereof, which process comprises a) resolving the racemic alpha-[(methylamino)-methyl]-9-10-ethanoanthracene- 9(10H)-ethanol and isolating S-(+)-alpha-[(methylamino)-methyl]-9-10-ethano anthracene-9(10H)-ethanol, if desired in the form of an acid addition salt, or b) reacting a compound of the formula II  see diagramm : EP0014434,P12,F1  with a compound of the formula III X2 -CH3 wherein one of X1  and X2  is the amino group and the other is a reactive esterified hydroxyl group, and Y1 is a free hydroxyl group, and X1 together with Y1  can also be an epoxy group, and A is the 9,10-ethanoanthracen-9(10H)-yl radical, or c) in a compound of the formula IV  see diagramm : EP0014434,P12,F2  in which at least one of Z1  and Z2  is a removable radical and the other may be hydrogen, or Z1  and Z2 together are a divalent removable radical, and A is the 9,10-ethanoanthracen-9(10H)-yl radical, removing Z1 and/or Z2 , d) reducing a compound which differs from the compound of the formula I only in that, in said compound, a carbon atom adjacent to the nitrogen atom is attached to this latter through a double bond or is substituted by a hydroxyl group or an oxo radical, optionally together with lower alkoxy, or e) adding ethylene to S-alpha-[(methylamino)-methyl]-9(10H)-anthracene, or hydrolyzing the intermediate obtained, and, if desired, converting the resultant S-(+)-alpha-[(methylamino)methyl]-9,10-ethanoanthracen- e-9(10H)-ethanol into an acid addition salt and/or liberating the base from a resultant acid addition salt.
Patent ES-513605-A0 (ES)
IPC: C04B41/50
Filed: 1982-06-30
Abstract: In the electrolytic production of aluminum by electrowinning or electrorefining processes, cell components such as cathode current feeders which in use are normally covered with molten aluminum are made of a composite material of aluminum or an aluminum alloy or intermetallic compound with an aluminum oxycompound, usually alumina, and possibly containing minor amounts of additives such as borides carbides, nitrides or oxides. The composite material, which remains mechanically stable and electrically conductive at 1000 DEG  C., may be prepared by hot pressing powders at 1000 DEG -1700 DEG  C. possibly after surface treating the alumina to improve wettability by molten Al. The components are optionally coated, e.g. with TiB2. The composite materials are also useful as non-current carrying components, including separator walls, weirs, packing elements and baffles.
Patent ES-515600-A0 (ES)
IPC: C10M169/00
Filed: 1982-09-09
Abstract: A grease composition suitable as a lubricating sealant which is resistant to aprotic solvents such as chloroform and carbon disulfide comprises glycerine, fumed silica, polyethylene glycol and a minor amount of water. A preferred grease composition is one in which the amount of glycerine ranges is from 50 to 95 weight % of the total composition, the amount of fumed silica is from 1 to 25% by weight of the total composition, the amount of polyethylene glycol ranges is from 0.5% to 50% by weight of total composition and the amount of water is from 0.01% to 1.0% by weight of total composition, the total composition amounting to 100%.
Patent ES-518331-A0 (ES)
IPC: G01S17/50
Filed: 1982-12-17
Abstract: The invention relates to a method and apparatus for measuring the velocity of a moving object. Measuring beams composed of sequences of optical pulses are directed towards the object which is to be measured and follow such object. Based upon transit time measurements of reflected pulses there are formed distance values and distance difference values. While taking into account the time interval of the pulse sequence there are computed velocity measuring values and velocity values computed from homogeneous groups of values are displayed as reliable velocity values. By means of a measuring beam deflection system there are directed measuring beams into defined solid angle sectors towards the object which is to be measured, and reliable velocity measuring values computed from homogeneous groups of measuring values from the measuring channels correlated to the individual solid angle sectors are displayed as binding or valid velocity measuring values if there is present a confirmation of the value from further solid angle sectors.
Patent ES-522814-A0 (ES)
IPC: C07D407/04
Filed: 1983-05-30
Abstract: Pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives of the formula Iwherein R' and R" are hydrogen, an unsubstituted or substituted hydrocarbon radical, or heterocyclic radical, halogen, formyl, free or functionally modified carboxyl, free or etherified or esterified hydroxyl, free, etherified or oxidized mercapto, unsubstituted or substituted sulfamoyl, acyl or unsubstituted or substituted amino, where however R' and R" cannot both be hydrogen simultaneously, and R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, R<sub>4</sub> and R<sub>5</sub> are each hydrogen or an unsubstituted or substituted hydrocarbon radical, and R<sub>2</sub> and R<sub>3</sub> together can also be an unsubstituted or substituted methylene group, and R<sub>1</sub> also an acyl group or an amidated carboxyl group; and therapeutically applicable salts of these compounds, as well as new compounds of these preparations.These pharmaceutical preparations are particularly valuable for treating liver and venous diseases.
Patent ES-534533-A0 (ES)
IPC: C07D257/06
Filed: 1984-07-20
Abstract: 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and its pharmaceutically acceptable salts are useful as antiallergic agents. The compounds are prepared by the reaction of 2-amino-N-(1H-tetrazol-5-yl)benzamide with formic acetic anhydride.
Patent ES-548859-A0 (ES)
IPC: F16L27/00
Filed: 1985-11-14
Abstract: A joint coupling comprises two pipe pieces (1), (5), which are in constant mutual communication and are partly inserted one into the other by way of respective curved portions (4,6) under fluid-tight engagement, said curved portions (4,6) being arranged for swivelling about a common axis (12) situated external to the joint coupling and containing the common centre of curvature of said curved portions (4,6). Means (13, 14, 15) are provided for locking/releasing the pipe pieces (1,5).
Patent ES-557620-A0 (ES)
IPC: A01N43/80
Filed: 1987-06-16
Abstract: The invention relates to a novel 3-acylaminobenzisothiazole-S,S-dioxide of formula I    <IMAGE>  (I). to the preparation thereof, to insecticidal compositions containing said compound and to the use thereof for controlling insects, in particular plant-destructive sucking insects.
Patent FI-821514-A0 (FI)
Inventor: WU EDWIN SHEN-CHOU
IPC: C07D311/36
Filed: 1982-04-29
Abstract: Chromone derivatives such as 7-(3-n-propylamino-2-hydroxypropoxy)-2,3-diphenylchromone which are useful as antihypertensive agents.
Patent FI-823758-A0 (FI)
Inventor: SCHARF UDO
IPC: A23L29/00
Filed: 1982-11-03
Abstract: Functional hydrolyzates are prepared from microbial protein isolates, with a protein content of more than 90% by weight, a nucleic acid content of less than 2% by weight, a lipid content of less than 1% by weight, a suspendability of 80-100%, a foaming capacity characterized by a foaming index of 4-7, a foam stability characterized by a half-life of 10-300 minutes, an emulsifying capacity characterized by a value of 300-500 ml of oil/g of protein, and a molecular weight of between 125,000 and 100 Daltons. The functional hydrolyzates are obtained from microbial proteins by enzymatic hydrolysis, after extraction of the nucleic acids and lipids. The hydrolyzates are suitable as food additives.
Patent FI-843317-A0 (FI)
Inventor: TROKHAN PAUL DENNIS
IPC: D21F1/10
Filed: 1984-08-22
Abstract: @ Foraminous members (19) useful in making paper webs. The faraminous member of this invention has a macroscopically monplanar, patterned, continuous network surface (23) which serves to define within the member a plurality of discrete, isolated, deflection conduits (22). A foraminous woven element (43), such as a screen, is thoroughly coated with liquid photosensitive resin to a controlled depth above the upper surface of the woven element. A mask or a negative having opaque and transparent regions which define the pattern is brought into contact with the surface of the liquid photosensitive resin and the resin is exposed to light of an activating wavelength through the mask. The resin exposed to the activating light is hardened (cured). Uncured resin is removed from the composite leaving behind the woven element with the solid network formed by the cured resin.
Patent FI-862919-A0 (FI)
Inventor: WEISSHUHN ELMER
IPC: D21F1/02
Filed: 1986-07-11
Abstract: 1. A headbox system for a paper-making machine with a distribution box (1) and a guide device (2) connected thereto for guiding a suspension of fibre materials in the direction of the machine (M) and for distributing the suspension across the width of the paper-making machine, the guide device (2) leading into a jet chamber (3) which has two limiting lips (4, 5) and a delivery gap (6) leading to the paper-making machine past a baffle (9), and at least one limiting lip (4, 5) of the jet chamber (3) having at least two sections (7, 8) inclined at different angles (alpha, beta) counter to the direction of flow (M) of the suspension in the jet chamber, the angle of inclination (alpha) of the section (7) of the upper lip (4) defining the jet chamber (3) and directly adjoining the guide device (2) being between 0 degree and 30 degrees, characterised in that the angle of inclination of the section (8) of the upper lip (4) located directly in front of the delivery gap (6) is between 60 degrees and 90 degrees, the length (x) of section (7) being a multiple of the length (y) of section (8).
Patent FI-870972-A0 (FI)
Inventor: DAPPERHELD STEFFEN
IPC: C25B3/25
Filed: 1987-03-05
Abstract: Chloroacetic and bromoacetic acids are dehalogenated by electrolysis of aqueous solutions of these acids using carbon cathodes and anodes likewise of carbon or of other conventional electrode materials in undivided or in divided electrolysis cells; the aqueous electrolysis solutions in the undivided cells and in the cathode area of the divided cells contain, in dissolved form, one or more salts of metals having a hydrogen excess-voltage of at least 0.4 V (at a current density of 4,000 A/m2). Metals having a hydrogen excess-voltage of at least 0.4 V (at a current density of 4,000 A/m2) are, for example, Cu, Ag, Au, Zn, Cd, Hg, Sn, Pb, Ti, Zr, Bi, V, Ta, Cr and Ni. The process allows high current densities (up to about 8,000 A/m2) to be used without or virtually without corrosion of the electrodes and without deposit formation on the electrodes.
Patent FI-885768-A0 (FI)
Inventor: SCHIEL CHRISTIAN
IPC: D21F3/02
Filed: 1988-12-13
Abstract: In a papermaking machine, the wire section (10-12) is followed immediately by a first longitudinal-gap press (20) in which a flat press gap is formed between a press roller (22) and a flexible press tube (23). The press gap can be pressed against the press roller (22) by a press shoe (24). The press roller (22) is located below the flexible press tube (23) so that the action of the press shoe (24) is directed vertically downwards. The fibrous material web (9) from which the water is to be extracted runs, together with an upper felt (13) and a lower felt (15), on a linear running section at a slight upward inclination to the wire section in the direction of the press gap of the first longitudinal-gap press (20). Behind this first longitudinal-gap press (20) is a second longitudinal-gap press (30), in which the press roller (32) is arranged above the flexible press tube (33) so that the action of the press shoe (34) is directed vertically upwards.
Patent FI-892202-A0 (FI)
Inventor: JANHUNEN TIMO
IPC: A61G15/16
Filed: 1989-05-08
Abstract: PCT No. PCT/FI90/00098 Sec. 371 Date Oct. 28, 1991 Sec. 102(e) Date Oct. 28, 1991 PCT Filed Apr. 10, 1990 PCT Pub. No. WO90/13269 PCT Pub. Date Nov. 15, 1990.This invention relates to a rack for instruments, especially dental instruments (1) comprising a drum (2) mounted so as to revolve about a shaft (4), compartments (5) being provided on the periphery of the drum for at least one instrument (1) and its holder (3); an instrument supply line (6) arranged to be connected to one instrument (1) at a time; and a stationary outer casing (7) surrounding the drum (2) and provided with at least one opening for pulling out at least the instrument connected to the supply line. In the invention, to further improve the sterility of the instruments, walls (8) separating the compartments (5) of the drum (2) are sealed (9) relative to the outer casing (7); and the outer casing (7) is provided with means (10, 11, 12) for sterilizing the instruments (1) when they are not being used.
Patent FI-905066-A0 (FI)
Inventor: LEVINE ROBERT A
IPC: G01N15/05
Filed: 1990-10-15
Abstract: Blood constituents are separated by centrifugation in a transparent tube which contains a float for physically elongating certain of the constituents. The centrifuged sample in the tube is positioned on a layer measuring device with which red cell and buffy coat constituent band heights can be measured in ambient light. The buffy coat constituent measurements are made under optical magnification. The measuring device has a mathmatically derived red cell layer nomogram printed thereon, and a separate scale for measuring buffy coat constituent bands. Conversion tables are provided for converting the measured buffy coat constituent band lengths into constituent cell counts. The measuring device includes tube-engaging portions for properly positioning the tube during the measurements, and the red cell scale automatically compensates for the presence of the float and densification of red cells needed for proper banding.
Patent FI-915614-A0 (FI)
Inventor: DERBER BERND
IPC: G01N33/28
Filed: 1991-11-28
Abstract: For the reliable detection of a marking substance in mineral oils, a mineral oil sample is passed by means of a sampling and metering device (1) through a substance located in a container (2) and adsorbing the marking substance which is then selectively dissolved by rinsing the adsorbing substance with an eluent, and the eluate is then contacted in a receiving container (3) with a detection reagent for colour indication.
Patent FI-922839-A0 (FI)
Inventor: METCALF DONALD
IPC: A61K38/20
Filed: 1992-06-17
Abstract: PCT No. PCT/AU90/00592 Sec. 371 Date Jul. 27, 1992 Sec. 102(e) Date Jul. 27, 1992 PCT Filed Dec. 8, 1990 PCT Pub. No. WO91/08752 PCT Pub. Date Jun. 27, 1991The present invention relates generally to a method for, and pharmaceutical compositions useful in, the treatment of thrombocytopenia in a mammal by the administration of an effective amount of leukaemia inhibitory factor (LIF) and/or its derivatives and optionally in combination with one or more other cytokines.
Patent FI-924297-A0 (FI)
Inventor: BERG ARNE
IPC: A61K51/02
Filed: 1992-09-25
Abstract: The invention relates to the use as contrast enhacing agents in medical imaging, especially X-ray imaging, of multinuclear complexes, i.e. complexes, such as those of W2O2( mu 2O)2, in which the complexed entity comprises at least two contrast enhancing atoms.
Patent FI-924454-A0 (FI)
Inventor: HLAVKA JOSEPH J
IPC: A61K31/426
Filed: 1992-10-02
Abstract: Novel 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds having activity against a wide spectrum of organisms including organisms which are resistant to tetracyclines are disclosed. Also disclosed are intermediates and methods for making the novel compounds of the present invention.
Patent FI-941569-A0 (FI)
Inventor: FALLON RENEE A
IPC: A61K9/70
Filed: 1994-04-06
Abstract: PCT No. PCT/US92/08631 Sec. 371 Date Mar. 16, 1994 Sec. 102(e) Date Mar. 16, 1994 PCT Filed Oct. 9, 1992 PCT Pub. No. WO93/06803 PCT Pub. Date Apr. 15, 1993A transdermal drug delivery device that administers drug in an initial pulse followed by a substantially lower continuous rate comprising a drug reservoir of the drug dissolved in a nonvolatile skin permeation enhancer and a volatile permeation enhancer confined between a backing that is permeable to the volatile permeation enhancer and an underlying substrate layer that is permeable to the drug and both enhancers. When the device is placed on the skin the volatile permeation enhancer is depleted from the reservoir by evaporation through the backing such that the magnitude and duration of the pulse is dependent upon the permeability of the backing layer to the volatile enhancer.
Patent FI-943689-A0 (FI)
Inventor: ZELLER MATHIAS
IPC: H02P6/34
Filed: 1994-08-09
Abstract: PCT No. PCT/CH93/00274 Sec. 371 Date Aug. 23, 1994 Sec. 102(e) Date Aug. 23, 1994 PCT Filed Dec. 7, 1993 PCT Pub. No. WO94/14219 PCT Pub. Date Jun. 23, 1994In the device, an electric motor is designed as a brushless, electronically commutated pancake motor (201) with permanent magnets arranged on the rotor and coreless windings arranged on the stator. Each winding is provided with a pair of terminals which can be connected in each case via a controllable switch at least to each phase conductor of the alternating power supply and to each other via a further controllable switch. In a device with pick-ups, the instantaneous voltage between one phase conductor each and a neutral conductor or another phase conductor of the alternating power supply, the instantaneous voltage between the two terminals of at least one pair of terminals, and also the instantaneous current in one winding each are repeatedly sampled. The sampled instantaneous voltages or currents are compared with one another and with corresponding threshold values in order to control the switches in dependence on the instantaneous result of the comparisons. The device allows a reversible conversion and storage of electric energy from an a.c. power supply into kinetic energy of an electric motor.
Patent FI-951456-A0 (FI)
Inventor: SMITS GUIDO F
IPC: C08J9/00
Filed: 1995-03-27
Abstract: A process for preparing a cellular polymer containing perforated cell windows in the presence of a perforating agent being a substance that has a critical surface free energy of less than about 23 mJ/m2 is disclosed. The cellular polymers obtained according to this invention have a fine cell structure and show enhanced dimensional and thermal insulation stability. The invention also relates to rigid polyurethane foam prepared in the presence of, for example, particulate poly(tetrafluoroethylene) or a liquid polyfluoro- or perfluorocarbon, with a boiling point of at least 130 degrees C., as perforating agent.
Patent FI-956094-A0 (FI)
Inventor: HENNIG ROLF
IPC: E06C5/40
Filed: 1995-12-18
Abstract: The ladder is turned by a bogie with a first ring mount on a vertical pivot axle (A). The first and second (6) ring mount move in relation to each other on an axis (S) at right angles to the pivot axis. The second ring mount is positioned directly above the substructure or in a platform (3) on the substructure. Above the second ring mount and beneath the first ring mount is a bearing plate (16,21) each of which is reinforced by tubular reinforcement frames (18,22).
Patent FI-965253-A0 (FI)
Inventor: OUTOKUMPU TECHNOLOGY OY
IPC: C22B1/20
Filed: 1996-12-30
Abstract: The invention relates to an apparatus for conducting gas through material (1) to be sintered, which material is set in an essentially continuous motion, particularly when gas is used for sintering the material; said apparatus comprises a flow guide (7) for conducting gas essentially near to the material (1) to be sintered, and a gas collecting member (10) for collecting the gas that has been made to penetrate the material to be sintered. According to the invention, in the gas flow guide (7) the gas inlet (8) is located centrally with respect to the material (1) to be sintered, and the gas outlet (9) extends essentially over the whole material to be sintered in the transversal direction, when observed in the proceeding direction of said material; and the gas collecting member (10) is composed of funnel elements (11), which are installed essentially at the gas flow apertures (5) provided in the member for conveying the material to be sintered.
Patent IL-72002-A0 (IL)
Title: Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
IPC: C07D499/87
Filed: 1984-06-04
Abstract: A process for the preparation of beta-lactamase inhibiting 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives. R- and S-1-(ethoxycarbonyloxy)ethyl 6-alpha-(aminomethyl)penicillanate 1,1-dioxide are specifically described.
Patent IL-84342-A0 (IL)
Title: Process for obtaining crystals of intermetallic compounds,in particular isolated monocrystals,by cooling alloys in the molten state
IPC: C30B11/00
Filed: 1987-11-02
Abstract: The invention relates to a process for obtaining crystals of intermetallic compounds, in particular isolated monocrystals, by cooling alloys in the molten state. The process involves using an alloy in the molten state which has a composition such that the first phase to crystallize during its solidification corresponds to the compound to be isolated, cooling it slowly by subjecting it to cyclic stirring and thermal cycling without attaining the temperature at which another solid phase appears then abruptly expelling the residual liquid. The process is used for obtaining large monophase primary crystals of compounds which melt congruently or incongruently, in particular compounds having symmetry of order 5 known as "quasi-crystals".
Patent IL-86258-A0 (IL)
Title: Pasteurizable,freeze-driable hemoglobin-based blood substitute
IPC: A61K38/42
Filed: 1988-05-03
Abstract: The present specification describes a process by which a blood substitute (hereinafter referred to as "HemoSafe") is derived from uniformly stabilized monomers and polymers of deoxyhemoglobin in its tight (T) conformation, with oxygen affinity similar to that of human blood. Two classes of HemoSafe are derived respectively from animal-hemoglobin and human-hemoglobin. HemoSafe (animal) differs from HemoSafe (human) in that it is free of polymers in order to reduce potential immunogenicity if used in man. Both types of HemoSafe may be derived in the following manner. The stabilized deoxyhemoglobins are converted to their carbonmonoxy derivatives (CO-HemoSafe) which are then stable under pasteurization conditions to render them viral disease transmission-free. CO-HemoSafes are stable for 2 months at 56 DEG C in either the solution or the freeze-dried state. For transfusion CO-HemoSafes are easily oxygenated under sterile conditions by photoconversion yielding oxy-HemoSafe. In addition a transfusable met-hemoglobin derivative for treatment of cyanide poisoning, is derived by converting oxy-HemoSafe to met-HemoSafe.
Patent IL-88280-A0 (IL)
Title: Antibacterial 9-deoxo-9alpha-allyl and propargyl-9alpha-aza-9alpha-homoerythromycin a derivatives
IPC: A61K31/395
Filed: 1988-11-03
Abstract: An antibacterial agent of the formula:- <CHEM> or a pharmaceutically acceptable acid addition salt thereof, wherein R is allyl or propargyl.
Patent IL-88619-A0 (IL)
Title: Non-peptidic renin inhibitors
IPC: C07D209/08
Filed: 1988-12-07
Abstract: Simple amides and derivatives thereof useful for inhibiting the angiotensinogen-cleaving action of the enzyme renin of the formula: <CHEM> wherein R1 is (C6-C8)cycloalkyl or i-propyl; R2 is (C3-C5)alkyl, phenyl, methylvinyl, dimethylvinyl, halovinyl, hydroxy(C1-C3)alkyl or amino(C1-C4)alkyl; R3 is (C1-C6)alkyl or morpholinoethyl; and Het is defined to include certain mono and bicyclic nitrogen-containing heterocyclic rings or heterocyclylalkyl groups.